NMRA Neumora Therapeutics, Inc. Common Stock
Healthcare$1.85+0.00%ClosedMarket Cap: $342.8M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$7.00
Target (Median)
$7.00
Target Range
$6.00 - $8.00
Upside from current price: 278.4%
Rating Distribution
2 Strong Buy5 Buy1 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-31 | Guggenheim | maintain | Buy | Buy |
| 2026-03-31 | Needham | maintain | Buy | Buy |
| 2026-02-17 | William Blair | upgrade | Outperform | Market Perform |
| 2025-12-01 | RBC Capital | upgrade | Outperform | Sector Perform |
| 2025-11-17 | Stifel | maintain | Hold | Hold |
| 2025-10-28 | Needham | maintain | Buy | Buy |
| 2025-10-27 | Guggenheim | upgrade | Buy | Neutral |
| 2025-09-16 | JP Morgan | downgrade | Underweight | Neutral |
| 2025-07-16 | Mizuho | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-1.05 | $625.0K | 7 |
| Fri Dec 31 | $-0.89 | $5.2M | 7 |
| Sun Dec 31 | $-0.83 | $62.2M | 8 |
| Mon Dec 31 | $-0.50 | $206.1M | 6 |